» Articles » PMID: 11318785

A Novel Homozygous Mutation in the Second Transmembrane Domain of the Gonadotrophin Releasing Hormone Receptor Gene

Overview
Specialty Endocrinology
Date 2001 Apr 25
PMID 11318785
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: Mutations in the GnRH receptor (GnRH-R) gene cause hypogonadotrophic hypogonadism. Here, we present the molecular studies of the GnRH-R gene in three families with isolated hypogonadotrophic hypogonadism.

Patients: Three unrelated families, with at least two members diagnosed with isolated hypogonadotrophic hypogonadism were included.

Measurements: DNA sequencing was performed after polymerase chain reaction amplification of each of the three exons of the gene.

Results: A novel homozygous missense mutation, at nucleotide 268, turning glutamic acid into lysine, located at the second transmembrane domain of the GnRH-R gene was found in two patients pertaining to one of the families studied. Both parents and an unaffected brother were heterozygous carriers of one mutant allele, an unaffected sister was homozygote wild type. In the other two affected families no mutations were found in the GnRH-R gene.

Conclusions: This constitutes the first description of an spontaneous mutation located at the second transmembrane domain (Glu90Lys) of the GnRH-R, indicating that the integrity of glutamic acid at this position is crucial for receptor function. Also this report, complementing others, demonstrates that mutations are distributed throughout the GnRH-R gene and that as in the only other homozygous mutation previously described, affected patients present a complete form of hypogonadotrophic hypogonadism. Due to the fact that apparently consanguinity was present in our affected family, we presume that the mutation derived from a common ancestor, by a founder gene effect.

Citing Articles

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism.

Fanis P, Neocleous V, Papapetrou I, Phylactou L, Skordis N Int J Mol Sci. 2023; 24(21).

PMID: 37958948 PMC: 10650312. DOI: 10.3390/ijms242115965.


Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.

Ulloa-Aguirre A, Zarinan T, Jardon-Valadez E Int J Mol Sci. 2021; 22(22).

PMID: 34830210 PMC: 8622668. DOI: 10.3390/ijms222212329.


Computational Analysis of Missense Variants of G Protein-Coupled Receptors Involved in the Neuroendocrine Regulation of Reproduction.

Min L, Nie M, Zhang A, Wen J, Noel S, Lee V Neuroendocrinology. 2015; 103(3-4):230-9.

PMID: 26088945 PMC: 4684493. DOI: 10.1159/000435884.


Assay strategies for identification of therapeutic leads that target protein trafficking.

Conn P, Spicer T, Scampavia L, Janovick J Trends Pharmacol Sci. 2015; 36(8):498-505.

PMID: 26067100 PMC: 4532603. DOI: 10.1016/j.tips.2015.05.004.


A phenotypic high throughput screening assay for the identification of pharmacoperones for the gonadotropin releasing hormone receptor.

Conn P, Smith E, Spicer T, Chase P, Scampavia L, Janovick J Assay Drug Dev Technol. 2014; 12(4):238-46.

PMID: 24831790 PMC: 4025569. DOI: 10.1089/adt.2014.576.